84 related articles for article (PubMed ID: 11097229)
1. Plasma concentrations of reputed tumor-associated soluble CD44 isoforms (v5 and v6) in smokers are dose related and decline on smoking cessation.
Scott DA; Stapleton JA; Palmer RM; Wilson RF; Sutherland G; Coward PY; Gustavsson G; Odell EW; Poston RN
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1211-4. PubMed ID: 11097229
[TBL] [Abstract][Full Text] [Related]
2. Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancer.
Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Cosio S; Prontera C; Bianchi R; Genazzani AR
Anticancer Res; 1997; 17(6D):4463-6. PubMed ID: 9494551
[TBL] [Abstract][Full Text] [Related]
3. Dramatic decline in circulating intercellular adhesion molecule-1 concentration on quitting tobacco smoking.
Scott DA; Stapleton JA; Wilson RF; Sutherland G; Palmer RM; Coward PY; Gustavsson G
Blood Cells Mol Dis; 2000 Jun; 26(3):255-8. PubMed ID: 10950946
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
[TBL] [Abstract][Full Text] [Related]
5. Soluble CD44 and CD44v6 serum levels in patients with colorectal cancer are independent of tumor stage and tissue expression of CD44v6.
Weg-Remers S; Hildebrandt U; Feifel G; Moser C; Zeitz M; Stallmach A
Am J Gastroenterol; 1998 May; 93(5):790-4. PubMed ID: 9625129
[TBL] [Abstract][Full Text] [Related]
6. The serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant 5 (sCD44-v5), and CD44 splice variant 6 (sCD44-v6) in patients with cervical cancer.
Gadducci A; Ferdeghini M; Cosio S; Annicchiarico C; Fanucchi A; Prontera C; Bianchi R; Genazzani AR
Anticancer Res; 1998; 18(1B):537-9. PubMed ID: 9568174
[TBL] [Abstract][Full Text] [Related]
7. Effect of nicotine replacement and quitting smoking on circulating adhesion molecule profiles (sICAM-1, sCD44v5, sCD44v6).
Palmer RM; Stapleton JA; Sutherland G; Coward PY; Wilson RF; Scott DA
Eur J Clin Invest; 2002 Nov; 32(11):852-7. PubMed ID: 12423327
[TBL] [Abstract][Full Text] [Related]
8. Serum concentration of total soluble CD44 is elevated in smokers.
Scott DA; Coward PY; Wilson RF; Poston RN; Odell EW; Palmer RM
Biomarkers; 2000; 5(3):240-4. PubMed ID: 23889226
[TBL] [Abstract][Full Text] [Related]
9. Effect of smoking cessation on markers of inflammation and endothelial cell activation among individuals with high risk for cardiovascular disease.
Halvorsen B; Lund Sagen E; Ueland T; Aukrust P; Tonstad S
Scand J Clin Lab Invest; 2007; 67(6):604-11. PubMed ID: 17852807
[TBL] [Abstract][Full Text] [Related]
10. Short-term benefit of smoking cessation in patients with coronary heart disease: estimates based on self-reported smoking data and serum cotinine measurements.
Twardella D; Küpper-Nybelen J; Rothenbacher D; Hahmann H; Wüsten B; Brenner H
Eur Heart J; 2004 Dec; 25(23):2101-8. PubMed ID: 15571825
[TBL] [Abstract][Full Text] [Related]
11. Significant elevation of tumour-associated isoforms of soluble CD44 in serum of normal individuals caused by cigarette smoking.
Kittl EM; Ruckser R; Rech-Weichselbraun I; Hinterberger W; Bauer K
Eur J Clin Chem Clin Biochem; 1997 Feb; 35(2):81-4. PubMed ID: 9056747
[TBL] [Abstract][Full Text] [Related]
12. Decline of DNA damage and other biomarkers in peripheral blood following smoking cessation.
Mooney LA; Santella RM; Covey L; Jeffrey AM; Bigbee W; Randall MC; Cooper TB; Ottman R; Tsai WY; Wazneh L
Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):627-34. PubMed ID: 8547829
[TBL] [Abstract][Full Text] [Related]
13. Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions.
Afify A; Lynne LC; Howell L
Diagn Cytopathol; 2007 Feb; 35(2):105-10. PubMed ID: 17230576
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of soluble CD44 splice variant v5 in the diagnosis and follow-up in breast cancer patients.
Kittl EM; Ruckser R; Selleny S; Samek V; Hofmann J; Huber K; Reiner A; Ogris E; Hinterberger W; Bauer K
Exp Clin Immunogenet; 1997; 14(4):264-72. PubMed ID: 9523162
[TBL] [Abstract][Full Text] [Related]
15. Sex-related differences in serum cotinine concentrations in daily cigarette smokers.
Gan WQ; Cohen SB; Man SF; Sin DD
Nicotine Tob Res; 2008 Aug; 10(8):1293-300. PubMed ID: 18686176
[TBL] [Abstract][Full Text] [Related]
16. Alterations of gene expression in human neutrophils induced by smoking cessation.
Morozumi T; Kubota T; Sugita N; Itagaki M; Yoshie H
J Clin Periodontol; 2004 Dec; 31(12):1110-6. PubMed ID: 15560814
[TBL] [Abstract][Full Text] [Related]
17. Smoking reduction and biomarkers in two longitudinal studies.
Godtfredsen NS; Prescott E; Vestbo J; Osler M
Addiction; 2006 Oct; 101(10):1516-22. PubMed ID: 16968354
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of self-reported smoking status among participants in a chemoprevention trial.
Martínez ME; Reid M; Jiang R; Einspahr J; Alberts DS
Prev Med; 2004 Apr; 38(4):492-7. PubMed ID: 15020184
[TBL] [Abstract][Full Text] [Related]
19. Urine cotinine as an index of smoking status in smokers during 96-hr abstinence: comparison between gas chromatography/mass spectrometry and immunoassay test strips.
Acosta M; Buchhalter A; Breland A; Hamilton D; Eissenberg T
Nicotine Tob Res; 2004 Aug; 6(4):615-20. PubMed ID: 15370157
[TBL] [Abstract][Full Text] [Related]
20. Relations of cotinine and carbon monoxide to self-reported smoking in a cohort of smokers and ex-smokers followed over 5 years.
Murray RP; Connett JE; Istvan JA; Nides MA; Rempel-Rossum S
Nicotine Tob Res; 2002 Aug; 4(3):287-94. PubMed ID: 12215237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
